Trending...
- CCHR Florida: Mental Health Awareness Month Open House
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
AIA Philadelphia's 2022 Forum on Architecture + Design discusses growing Life Science market in Philadelphia
PHILADELPHIA, Nov. 21, 2022 /PRNewswire/ -- On Thursday, Nov. 10, DPR Construction's Daniel Maldonado shared his thoughts on the burgeoning life sciences market in Philadelphia. The city has emerged as a hot new submarket for life science and biotechnology companies. With access to world-renowned healthcare and research institutions; a dense pool of talent from leading universities, centrally located between Boston, Maryland's I-270 corridor, and Raleigh-Durham; and an affordable, culture rich community, Maldonado said Philadelphia is where companies are investing.
Among his observations was that, as industry and manufacturing moved out of American cities, a large inventory of buildings was left and they are ripe for redevelopment. Couple that with a shift in workplace cultures coming out of the pandemic and more flexibility for remote work, companies are downsizing their workspaces, opening amenity rich inventory for small start-ups in prime locations that was once out of touch.
"Researchers and scientists are working hard to develop critical, life-saving medicines, vaccines, and treatments," said Maldonado. "We need to support them and help them get their product to market expeditiously. We start by understanding the needs of the company and help them devise a plan to bring their facility online in an efficient manner. Sometimes that's a new build, other times it's a retrofit or building conversion, the solution needs to meet their operational goals."
More on The PennZone
Leading Philadelphia's surge in prominence is the collaboration of the researchers, scientists, and companies. "They openly share their discoveries building upon the successes of one another to find solutions for their patients," Maldonado said. "By employing that same level of collaboration into the design and construction of new labs and manufacturing facilities, we can revolutionize how projects are being executed, reducing building development durations allowing treatments to be brought to market faster."
Leaders from across the AEC community joined Maldonado for the conversation. Phil Burkett AIA, WELL AP, LEED AP, NCARB of Meyer Design hosted the discussion with Nancy M. Kelley of NJK+A, and Neil Brazitis of Newmark sharing their thoughts on the innovations and developments in the life science market in Philadelphia.
About DPR Construction
DPR Construction is a forward-thinking, self-performing general contractor and construction manager specializing in technically complex and sustainable projects for the advanced technology, life sciences, healthcare, higher education and commercial markets. DPR's portfolio of work ranges from large-scale new construction to small tenant improvements and special projects. Founded in 1990, DPR is a great story of entrepreneurial success as a private, employee-owned company that has grown to a multi-billion-dollar organization with offices around the world. Strategically focused on delivering more predictable outcomes through applications of virtual design & construction, prefabrication, its corps of self-perform craft, and leveraging data to learn and improve from DPR consistently ranks among the top building contractors and employs approximately 10,000 professionals across its family of companies. For more information, visit http://www.dpr.com.
More on The PennZone
For more information, please contact:
Lisa Ruano
DPR Construction
Tel: 908-451-9622
Email: [email protected]
SOURCE DPR Construction
PHILADELPHIA, Nov. 21, 2022 /PRNewswire/ -- On Thursday, Nov. 10, DPR Construction's Daniel Maldonado shared his thoughts on the burgeoning life sciences market in Philadelphia. The city has emerged as a hot new submarket for life science and biotechnology companies. With access to world-renowned healthcare and research institutions; a dense pool of talent from leading universities, centrally located between Boston, Maryland's I-270 corridor, and Raleigh-Durham; and an affordable, culture rich community, Maldonado said Philadelphia is where companies are investing.
Among his observations was that, as industry and manufacturing moved out of American cities, a large inventory of buildings was left and they are ripe for redevelopment. Couple that with a shift in workplace cultures coming out of the pandemic and more flexibility for remote work, companies are downsizing their workspaces, opening amenity rich inventory for small start-ups in prime locations that was once out of touch.
"Researchers and scientists are working hard to develop critical, life-saving medicines, vaccines, and treatments," said Maldonado. "We need to support them and help them get their product to market expeditiously. We start by understanding the needs of the company and help them devise a plan to bring their facility online in an efficient manner. Sometimes that's a new build, other times it's a retrofit or building conversion, the solution needs to meet their operational goals."
More on The PennZone
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- Author Chandra Donelson Visits the Children's Museum of Pittsburgh
- Chandra Donelson Headlines the Hike2 Innovation Summit 2025
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
Leading Philadelphia's surge in prominence is the collaboration of the researchers, scientists, and companies. "They openly share their discoveries building upon the successes of one another to find solutions for their patients," Maldonado said. "By employing that same level of collaboration into the design and construction of new labs and manufacturing facilities, we can revolutionize how projects are being executed, reducing building development durations allowing treatments to be brought to market faster."
Leaders from across the AEC community joined Maldonado for the conversation. Phil Burkett AIA, WELL AP, LEED AP, NCARB of Meyer Design hosted the discussion with Nancy M. Kelley of NJK+A, and Neil Brazitis of Newmark sharing their thoughts on the innovations and developments in the life science market in Philadelphia.
About DPR Construction
DPR Construction is a forward-thinking, self-performing general contractor and construction manager specializing in technically complex and sustainable projects for the advanced technology, life sciences, healthcare, higher education and commercial markets. DPR's portfolio of work ranges from large-scale new construction to small tenant improvements and special projects. Founded in 1990, DPR is a great story of entrepreneurial success as a private, employee-owned company that has grown to a multi-billion-dollar organization with offices around the world. Strategically focused on delivering more predictable outcomes through applications of virtual design & construction, prefabrication, its corps of self-perform craft, and leveraging data to learn and improve from DPR consistently ranks among the top building contractors and employs approximately 10,000 professionals across its family of companies. For more information, visit http://www.dpr.com.
More on The PennZone
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Actuated Medical Launches Participating Preferred Series A Round, Led by Keiretsu Forum Mid-Atlantic, South-East, & Texas
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
For more information, please contact:
Lisa Ruano
DPR Construction
Tel: 908-451-9622
Email: [email protected]
SOURCE DPR Construction
Filed Under: Business
0 Comments
Latest on The PennZone
- ABM for Good™ Launches First Project with Build Change
- Braces for Teenagers in Allentown Offered by Exeter Smiles
- Roots for Boots to Host "Bike Day Bash" Featuring Trike Presentation to Local Veteran
- JOSHWAY Cuts Ribbon on New Brick-and-Mortar Location
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
- GormanSquared Announces Provisional Patent
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- Chewy Chums™ Launches NeverBite™ on Kickstarter
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
- Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma